Exploring the limited use of transdermal medications in psychiatry: Challenges and potential solutions

doi:10.5662/wjm.v14.i4.96145

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 14, Issue 4

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (984)

All Articles published online

The chart showing PDF series, HTML series.

Item

Count

PDF

HTML

878

Sum=895

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

Download

Sum=71

Dec 20, 2024 (publication date) through Sep 8, 2024

Times Cited of This Article

Times Cited (0)

Journal Information of This Article

Publication Name

World Journal of Methodology

ISSN

2222-0682

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Editorial

World J Methodol. Dec 20, 2024; 14(4): 96145
Published online Dec 20, 2024. doi: 10.5662/wjm.v14.i4.96145

Exploring the limited use of transdermal medications in psychiatry: Challenges and potential solutions

Mandeep Kaur, Meera Patel, Elizabeth Monis

Mandeep Kaur, Meera Patel, Elizabeth Monis, Department of Psychiatry and Behavioral Health, Cape Fear Valley Medical Center, Fayetteville, NC 28305, United States

Author contributions: Kaur M designed the research study; Kaur M, Patel M, Monis E performed the research and wrote the manuscript; Kaur M revised the manuscript.

Conflict-of-interest statement: All the authors declare that they have no conflict of interest.

Open-Access: This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/

Corresponding author: Mandeep Kaur, MD, Assistant Professor, Staff Physician, Department of Psychiatry and Behavioral Health, Cape Fear Valley Medical Center, 711 Executive Place, 4^th Floor, Fayetteville, NC 28305, United States. mandy.drmandeep@gmail.com

Received: April 28, 2024
Revised: June 29, 2024
Accepted: July 10, 2024
Published online: December 20, 2024
Processing time: 89 Days and 6.5 Hours

Core Tip

Core Tip: The field of psychiatry is advancing at an exponential rate. The advancements made in the diagnostic and treatment modalities for various psychiatric conditions is exemplary. Transdermal route of medication delivery has been around for past few decades, however, this route has not been a favorable route in psychiatry practices due to various biochemical, patient as well as clinician preferences. In this editorial article we discuss this issue and bring forward some potential solutions to make transdermal medication delivery as a viable option in the area of psychiatry.